Novo Nordisk A/S News Headlines

NVO 
$45.07
*  
0.98
2.13%
Get NVO Alerts
*Delayed - data as of Aug. 1, 2014  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Regulatory Setback for Eli Lilly - Analyst Blog
3/6/2014 1:00:01 PM - Zacks.com

Novo Nordisk (NVO) Enters Oversold Territory - Tale of the Tape
3/6/2014 10:24:01 AM - Zacks.com

Promising Data on Merck Allergy Drug - Analyst Blog
3/5/2014 6:50:01 PM - Zacks.com

Update on Bayer/Regeneron's Eylea - Analyst Blog
3/5/2014 5:55:01 PM - Zacks.com

Setback for Roche - Analyst Blog
3/4/2014 4:55:01 PM - Zacks.com

Eli Lilly Gains Slightly on Dulaglutide Data - Analyst Blog
2/27/2014 5:45:01 PM - Zacks.com

Dividend Contenders: 25 Increases Expected In The Next 11 Weeks
2/14/2014 12:27:00 AM - Seeking Alpha

Positive Phase I Data from Biodel - Analyst Blog
2/13/2014 6:40:01 PM - Zacks.com

Is There Investment Upside In The Future Of Treating Diabetes?
2/10/2014 8:01:00 AM - Seeking Alpha

Novo-Nordisk As (NVO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
2/10/2014 8:00:01 AM - Zacks.com

Update on Novo Nordisk's Diabetes Pipeline - Analyst Blog
2/7/2014 5:55:01 PM - Zacks.com

Novo Nordisk Gives anti-NKG2A Rights to Innate - Analyst Blog
2/6/2014 5:45:01 PM - Zacks.com

The Dream Of The Insulin Pill: Oramed Vs. Rivals
2/6/2014 6:51:00 AM - Seeking Alpha

European Shares Mixed, But Trade Cautious Ahead of US Jobs Data on Friday
2/5/2014 1:18:14 PM - MT Newswires

Weekly 52-Week Highs Highlight: ACT, NVO, NXPI, WYNN
2/3/2014 1:48:59 PM - GuruFocus

Novo Nordisk Beats on Q4 Earnings - Analyst Blog
1/31/2014 4:30:01 PM - Zacks.com

European Bourses Ease As Inflation Drop Ignites Worries of Deflation
1/31/2014 1:24:28 PM - MT Newswires

European Shares Mixed, Pare Early Losses Made on Weak China PMI and Fed Tapering
1/30/2014 1:19:53 PM - MT Newswires

CHMP Positive on Glaxo's Eperzan - Analyst Blog
1/27/2014 7:30:01 PM - Zacks.com

Amgen: The Best Value In Biotech
1/24/2014 10:45:00 AM - Seeking Alpha

Pre-Market Most Active for Jan 24, 2014 : AA, NOK, TS, MSFT, MT, NVO, LYG, QQQ, BBRY, ARIA, FB, XIV
1/24/2014 9:39:39 AM - NASDAQ.com News

EU Approval for AstraZeneca's Xigduo - Analyst Blog
1/23/2014 5:00:01 PM - Zacks.com

Novo Nordisk Launches NovoFine Plus - Analyst Blog
1/21/2014 7:50:01 PM - Zacks.com

Dividend Contenders: 34 Increases Expected In The Next 11 Weeks
1/17/2014 11:10:00 AM - Seeking Alpha

Sanofi's LixiLan Progresses - Analyst Blog
1/16/2014 7:20:01 PM - Zacks.com